Alzheimer’s drug memantine is associated with an increased risk of pneumonia compared to other anti-dementia drugs.

- Currently there is no cure for Alzheimer’s disease, progression can be slowed down by use of anti-dementia drugs.
- Persons with Alzheimer’s disease have an elevated risk of pneumonia; common cause of death and hospitalization in this population
- Anti-dementia drug memantine linked to increased pneumonia risk





Results of the Study
Persons using:
- Donepezil or galantamine had the lowest risk of pneumonia
- Memantine or rivastigmine in patch form had a 1.6 and 1.15 times higher risk of pneumonia
- Rivastigmine in capsule form had no elevated risk of pneumonia.
Anti-dementia Drugs Used to Slow Down Alzheimer’s Disease Progression
- Acetylcholinesterase inhibitors such as donepezil, galantamine, and rivastigmine for early to moderate stages
- Memantine for moderate to severe stages
- Elderly people
- Those with weakened immune system
- Or those with underlying health conditions such as Alzheimer’s or dementia
Aspiration pneumonia is caused when food or liquid is breathed in and goes down the windpipe rather than the food pipe. It is one of the most common causes of death amongst people with Alzheimer’s disease.
- Depression
- Unreported pain, illness or medicine side effects
- Falling
- Malnutrition or dehydration
Source-Medindia